ArticleInternational journal of clinical oncology2026
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma.
Shinichi Makita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.